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Summary 
The importance of an alternative and sustainable supply of omega-3 long chain polyunsaturated 
fatty acids (LC omega-3) has long been established. As these biologically active fatty acids have 
an established role in nutrition and health, there is an ever increasing demand for oils containing 
LC omega-3 e.g. eicosapentaenoic (EPA) and docosahexaenoic acid (DHA). These fatty acids are 
produced by micoroganisms and enter our diet through the consumption of fish.  However, in order 
that the nutritional requirements of fish in aquaculture are met and sufficient levels are deposited to 
meet the requirements of human consumers, EPA and DHA must be supplied in excess. Given the 
importance of the aquaculture industry in delivering healthy foodstuff, the question of how to 
resource the supply of LC omega-3 then arises; traditional sources of EPA and DHA (fish oil) are 
challenged, whilst vegetable oils do not contain EPA or DHA. Therefore research efforts have 
focused on the successful reconstitution of LC omega-3 biosynthesis in oilseed crops. The 
production of EPA and DHA in the seed oil of agricultural crops has the capacity to deliver large 
volumes of these fatty acids., The expression of optimised combinations of the genes required to 
produce these fatty acids in the seed of the crop Camelina sativa has been achieved and the utility 
of this approach demonstrated, despite the difficulties confronted. . Furthermore, the stability and 
viability of the omega-3 LC trait has been proven in the field; and in separate studies, EPA-
Camelina oil has been shown to be a suitable substitute for fish oil. Taken together this represents 
a significant breakthrough - the provision of an effective alternative to the use of omega-3 fish oil 
by the global aquaculture industry. 
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Abbreviations 
CVD, cardiovascular disease; DHA, docosahexaenoic acid (22:6n−3); EFA, essential fatty acid; 
EPA, eicosapentaenoic acid (20:5n−3); FM, fishmeal; FO, fish oil; GM, genetically modified;  LC-
PUFA, long-chain polyunsaturated fatty acids (≥C20 ≥ 3 double bonds); LC omega-3, LC-PUFA 
predominantly EPA and DHA; MT, metric million tonnes; TAG, triacylglycerol; VO, vegetable oil.  
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1. Introduction  
In 2010, fish accounted for around 17 % of the global population’s intake of animal protein and 
almost 7% of all protein consumed.1 As well as being an important dietary sources of protein, 
minerals and vitamins,2 fish and seafood are also are the major sources of long chain (LC) omega-
3 polyunsaturated fatty acids, particularly eicosapentaenoic (EPA; 20:5ω3) and docosahexaenoic 
(DHA; 22:6ω3) acids,3 that have well-known beneficial effects in human health, including 
cardiovascular and inflammatory diseases, and important roles in neural development.4,5 However, 
global marine fisheries are stagnating and over 60% of fish stocks require rebuilding6 so that an 
increasing proportion of fish are farmed, reaching almost 50% in 20121.  Paradoxically, feeds for 
many farmed fish species are dependent on fishmeal and fish oil, themselves derived from marine 
fisheries, for the supply of LC omega-3.7 Reliance on finite marine resources was an unsustainable 
practice8 and the continued growth of aquaculture has been dependent upon the development of 
more sustainable feeds with alternative ingredients, generally derived from terrestrial agriculture, 
that lack LC omega-3.9 This has important consequences for the supply of these nutrients to 
human consumers and so there has been a global drive to find alternative supplies of LC omega-3 
fatty acids for aquaculture.10 The most promising and viable option for entirely new sources of LC 
omega-3 are transgenic oilseed crops. 
 
2. Long chain omega-3 and human health 
       It has long been appreciated that dietary LC omega-3 can have important, generally beneficial 
effects on human health.11 The strongest evidence has been found in relation to heart and 
cardiovascular disease (CVD)12; today a large number of national health agencies and government 
bodies recognize the importance of increasing dietary intake of EPA and DHA to promote cardiac 
health and decrease the risk of CVD.12,13 Recently, the current advice and guidelines worldwide 
were comprehensively reviewed14 and recommendations of over 50 organisations were compiled 
by the Global Organisation for EPA and DHA.15 Most recommendations suggest between 250 and 
500 mg/d of EPA and DHA for reducing CVD risk or 1 g/d for secondary prevention in existing CVD 
patients, with a dietary strategy for achieving 500 mg/d being to consume two fish meals (200 – 
250 g) per week with at least one of oily fish14, 16, 17 (Table 1). 
     In addition to cardiac health and CVD, dietary LC omega-3 can be beneficial for inflammatory 
diseases obtained in rheumatoid arthritis, in which the dose required to gain benefit is set higher 
than for CVD (around 3g per day18). There is also increasing evidence for beneficial effects of 
dietary LC omega-3 in Inflammatory Bowel Diseases (IBD) such as Crohn’s disease and ulcerative 
colitis.19 The effects of dietary LC omega-3 on cancers has been more controversial. 
Epidemiological studies indicated that, in general, dietary LC-omega-3 may decrease risk of colo-
rectal, breast and prostate cancers20 and some studies suggest beneficial effects in 
chemotherapy21. However, one research group suggested that LC-omega-3 may be associated 
with increased risk of prostate cancer;22,23 although latterly a second systematic review and meta-
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analyses of all studies concluded that the results did not support an association between LC 
omega-3 and prostate cancer.24 
      With regard to development, there is robust evidence that decreased DHA status can lead to 
cognitive and visual impairment and that DHA supplements have positive beneficial outcomes in 
pre-term infants.25There have also been several reports of potential beneficial effects of dietary 
DHA supplementation in a number of psychological/behavioural/ psychiatric disorders including 
attention deficit hyperactivity disorder and depression although there are insufficient studies and 
data to draw firm conclusions.26 However, it is becoming generally recognized that LC omega-3 are 
potential key nutrients to prevent various pathological conditions associated with the normal aging 
process,27 which has prompted research into the effects of LC omega-3 on dementia, including 
Alzheimer’s disease and other age-related cognitive impairments.28 In general, DHA 
supplementation trials in patients with some pre-diagnosed cognitive impairment indicated that this 
appeared to slow progression of Alzheimer’s.29 
 
3. Aquaculture: requirement for LC omega-3 
Vertebrates, including fish, cannot synthesise polyunsaturated fatty acids (PUFA) because they 
lack the enzymes required for their production from monounsaturated fatty acids and so they are 
essential in the diet. Terrestrial plants can be rich in medium chain PUFA such as linoleic acid 
(18:2ω6) and α-linolenic acid (LNA, 18:3ω3), but the biologically active fatty acids in fish are the 
long-chain PUFA, primarily EPA and DHA. Some freshwater and salmonids species of fish can 
produce EPA and DHA from LNA, but most marine fish cannot. In consequence, which PUFA can 
satisfy the essential fatty acid (EFA) requirements in fish vary with species.30, 31 The actual EFA 
requirement in fish can be described at three levels. The amount of EFA a fish requires to prevent 
nutritional pathology is low, often around 1% of the diet.30, 31 However, a higher level of EFA may 
be required to support optimum growth and health, which is similar to the situation in humans 
where few people suffer from EFA deficiency but, rather, LC omega-3 is required for optimal 
development and health. The final EFA requirement level in fish is that to maintain nutritional 
quality based on LC omega-3 content of the flesh.9 As such, this is not a requirement of the fish, 
but rather that of human consumers.32 To satisfy this level, EPA and DHA need to be supplied to 
the fish well in excess of the requirements for optimal health and growth so that they are deposited 
and stored in the fish. For example, to produce farmed salmon with the level of EPA and DHA 
required to supply the weekly human requirement of 3.5 g in one 130 g portion, it would be 
necessary for EPA plus DHA to be at 6 - 7% of diet.33 
This level o supplementation would make fish-farming commercially uneconomical. 
4. Fish Oil 
In 2013 around 75% of total global fish oil supply was used in aquaculture, with 83% of that 
consumed by salmonids (60%) and marine fish (23%), and a further 21% used for direct human 
consumption34 (Figs.1A &B). Despite continued growth of aquaculture1, the use of fish oil for feeds 
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has been relatively stable over the last decade with, on average, around 0.8 million metric tonnes 
(MT) being used34 (Fig.1C). The primary constraint with fish oil is that it is a finite resource with 
production limited through strict regulation of fishing and catch quotas.35, 36 Although production of 
fish oil has declined in recent years, largely due to regulation and quotas in South America,37 this 
has been partially offset by increased use of seafood and aquaculture by-products including by-
catch and trimmings to produce fish meal and, to a lesser extent, fish oil.36 However, fish oil 
production averages around 1 million MT annually and there is little to no prospect of that 
increasing.  
    Production of fish oil is also subject to environmental influences and acute phenomena such as 
El Niño have well-known consequences, considerably reducing supply.38 Sustainability issues are 
also key drivers limiting fish oil supplies, and these will have an increasing impact with the many 
initiatives currently being developed with respect to both national and international standards and 
certification of marine ingredients, including fish oil.33 Although increasing adoption and 
implementation of these standards will further improve sustainability, they will likely have impacts 
on the availability of fish oil and its use in aquaculture. A further factor constraining the use of fish 
oil is the presence of contaminants/undesirables such as persistent organic pollutants (POPS) 
including dioxins and PCBs.9, 39 With some fish oils, such as those from the Baltic, levels can be 
higher than permitted for use in animal feeds and these require decontamination before they can 
be used. However, this is an issue that has been diminishing to some extent with the increasing 
replacement of dietary fish oil and as a result levels of these undesirable marine environmental 
contaminants in feeds are decreasing.40 
    To put demand for fish oil (viz. LC omega-3) for aquaculture into perspective, to supply the 
salmon industry alone would require more than 1 million MT annually (i.e. greater than the average 
global supply). Thus the only way aquaculture has continued to grow has been by increasing 
substitution with alternative oils.10Global oil and fat production was more than 185 million MT in 
2012, with total production of vegetable oils at over 160 million MT, and animal fats including 
tallow, lard and butter totalling another 25 million MT. Thus, alternative oils are plentiful although 
they all lack LC omega-3 (Table 2). Terrestrial plants do not produce EPA and DHA and so they 
are not components of any vegetable oil, and animal fats are dominated by saturated and 
monounsaturated fatty acids with only low levels of PUFA (Table 3).  The consequence of this has 
been the increasing substitution of fish oil with alternative oils, effectively spreading the available 
fish oil thinner in the feeds, which has inevitably led to a reduction in LC omega-3 levels in both 
feeds and farmed fish10 (Table 4).  
     However, the issues surrounding the limited supply of LC omega-3 transcend aquaculture. 
Based on the most commonly recommended dose for cardiac health (500 mg/day15), the demand 
for LC omega-3 is over 11/4 million MT whereas global supply is optimistically estimated at just over 
0.8 million MT indicating a shortfall of over 0.4 million MTs41 (Table 5). The majority of supply 
(almost 90%) is from capture fisheries, whether as food fish or via fish oil and meal, with small 
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additional amounts estimated from seafood by-products, unfed aquaculture and algal sources. The 
calculations in Table 5 contain assumptions and estimates and so the precise extent of the 
difference can be the argued, however, that there is a gap between supply and demand is not in 
question irrespective of how it is calculated.42 There is a fundamental, global lack of LC omega-3 to 
supply human needs, whether by direct consumption or via aquaculture.  
 
5. Alternative sources of omega-3 LC-PUFA 
There is an urgent need for alternative sources of the LC omega-3, EPA and DHA.41 As the 
primary producers of almost all LC-omega-3 are marine microalgae and bacteria, the only 
alternatives to traditional fish oil are other oils sourced from the marine environment including lower 
trophic levels (zooplankton), mesopelagic fish, by-catch/by-products and microalgae themselves. 
 
Lower trophic levels  
Zooplankton such as krill and calanoid copepods in the southern and northern hemispheres, 
respectively, are possible options but, although biomass at lower trophic levels is large, there are 
inherent dangers associated with fishing down the marine food web.43 Potentially, zooplankton can 
be good oil sources, but harvesting of krill and copepods poses significant technological challenges 
and cost.44 For most species, lack of schooling behaviour makes harvest by traditional trawling 
technology an expensive economic option.44 Antarctic krill, which do form schools, are the only 
species being targeted for commercial harvest, apart from a small scientific quota (~1000 MT) of 
the calanoid copepod, Calanus finmachicus.45 Krill meals, that contain residual oil and therefore 
some LC omega-3, are currently used in some premium feeds focussed on health benefits and are 
generally used sparingly. These krill meals are therefore not being used as primary sources of LC 
omega-3 and, currently, krill oils are used almost exclusively for the human nutraceutical market.  
Although there may be evidence that harvesting krill, and potentially copepods, could be 
sustainable, there are still significant environmental and ecological concerns.44 For instance, 
Antarctic krill are near the base of a food chain that includes whales and penguins, suggesting 
there could be opposition to greatly increased exploitation.46  
 
Mesopelagic fish 
Mesopelagic fish that inhabit the intermediate pelagic water masses between the euphotic zone at 
100m depth and the deep bathypelagic zone at 1000m are available in potentially large quantities 
(1 - 6 billion MT), with lantern fish, myctophids, constituting about 60% of biomass.47 Different 
species can contain between 16 and 60 % of dry weight48 as oil and most are potentially good 
sources of LC omega-3.44 On the positive side, they are resources that, so far, have not been the 
subject of commercial exploitation, and they do not compete with existing or potential human feed 
production. Negative points include biological (seasonal variation), ecological (mixed fishery 
difficult to manage), technical (capture methods and on-board processing), and nutritional issues.  
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By-catch and seafood processing by-products  
In almost all fisheries there are non-target catch and/or discarded target catch that, together, make 
up the by-catch. However, both the precise definition and resultant estimates of by-catch can be 
controversial.49 In 2005, the discard rate was estimated at around 7 million MT/year or 8% of the 
global catch.50 By its nature, by-catch is a diffuse resource51 and this imposes a major limitation to 
its usefulness as a source of FO, although processing of by-products, including oil production, at 
sea is an increasing trend52. Another limitation is that by-catch includes a multitude of species, not 
necessarily “oily”, which limits the quantity and quality of the oils produced.51  
    Seafood industry by-products including viscera, heads, carcasses and trimmings, particularly 
those produced from pelagic fisheries and aquaculture are another potential source of marine oil 
although this is largely dictated by species. Thus, by-products from oily species including salmon, 
herring and mackerel can be a source of substantial oil whereas by-products from other pelagic 
(white fish) fisheries have generally low oil contents.53 Liver from species like cod and halibut have 
traditionally been used for fish oil production, but production is now relatively small (~ 40,000 MT) 
and goes mostly for direct human consumption as vitamin supplements as much as sources of LC 
omega-3.54 Oil is now being actively recovered from aquaculture species waste, particularly 
salmon farming, with around 20,000 MT reportedly recovered in Norway55 and 50,000 MT in Chile 
in 2006.56 
 
Marine microalgae  
Potentially, culture of the main primary producers, marine microalgae, could offer a long-term 
solution to the sustainable supply of LC omega-3.57 Various photosynthetic microalgae are already 
commonly used in fish hatcheries to supply both EPA (e.g. diatoms) and DHA (e.g. flagellates) in 
the rearing of larval marine crustacean and fish species.58 Production usually employs medium- to 
high-density batch, semi-continuous or continuous culture in relatively small volumes59. Up-scaling 
of production to the volumes required for algal oil and/or algal biomass to supply the amount of LC 
omega-3 required to replace fish oil in commercial aquafeed production has significant biological 
and technological challenges.60 Economic production of LC omega-3 would require algae to 
demonstrate simultaneous high growth and high oil content with high proportions of EPA and DHA. 
These are almost exclusive traits as oil deposition is usually  associated with conditions  which 
occur only when growth is limited (e.g. N limitation).61 Technical challenges include efficient 
capture of light energy in high-density culture with effective temperature control. These issues 
remain to be solved but there are several research strategies targeting their solution. These 
include exploiting culture conditions to direct metabolism towards lipid production, to improve 
biomass productivity or oil yield by mutagenesis and selective breeding, and to improve strains by 
genetic modifications to optimize light absorption and increase biosynthesis of EPA and DHA60. 
Therefore, in the future, algal species with favourable biological characteristics may be found 
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and/or developed, and photo-bioreactor technologies may improve considerably enabling 
economically sustainable production of microalgae rich in EPA and DHA for use in aquafeed.  
        In contrast, heterotrophic microalgae species including Crypthecodinium and thraustochytrids 
such as Schizochytrium are already being utilised for the commercial production of DHA using 
large-scale biofermentor technology.62 Even so, the high production costs are generally limiting the 
use of these products to direct human consumption mainly in the form of DHA supplementation of 
infant formulae.63 However, the DHA-rich products from heterotrophic microalgae may have niche 
markets in marine hatcheries, particularly for high-value species. Production volumes would have 
to be increased and costs reduced before these products could be viable for wider application in 
aquaculture.  
 
6. Plants as a source of omega-3 LC-PUFA 
It has long been the hope of researchers in the field of plant lipid biotechnology to produce a 
terrestrial supply of vegetable oil with a composition (EPA/DHA) matching that of fish oil. However, 
metabolic engineering on this scale is not trivial. Synthesis of LC omega-3 commonly occurs in 
marine microalgae via a series of sequential aerobic desaturation and elongation reactions. These 
reactions typically follow two routes – the ‘Δ6 pathway’ (Fig 2a) beginning with the Δ6-desaturation 
of the C18 substrate, C2 elongation and Δ5-desaturation or the much rarer ‘Δ8 pathway’ where the 
C18 substrate undergoes a C2 elongation, followed by two rounds of desaturation (Δ8, Δ5). To 
then generate DHA in either pathway requires a further C2 elongation and (Δ4) desaturation. 
Through whichever aerobic route, a minimum of three genes are required to synthesise EPA and 
five for DHA production. A further anaerobic route to LC omega-3 has been identified in some 
bacteria and unicellular marine eukaryotes and functionally characterised; this pathway uses a 
processive polyketide synthase-like enzymatic system to convert malonyl-CoA to EPA and DHA 
with the production of intermediates.64,65  
 
The activities and genes for each of the biochemical routes to LC omega-3 FA production have 
been characterised and are available for use by the metabolic engineer to reconstitute EPA/DHA 
synthesis in a suitable heterologous host.64 However, success can only be achieved by addressing 
some significant challenges: (1) the C18 di- or tri-unsaturated substrate must be pre-existing; (2) 
reconstitution of the pathway in a specific tissue (e.g. seed) requires the co-ordinated and targeted 
expression of multiple genes and activities; (3) the production of novel LC omega-3 and their 
correct acyl-exchange between lipid pools depends on the capacity of native endogenous enzymes 
that are unfamiliar with the fatty acids; and (4) the processes underpinning the biochemical acyl-
exchange or flux of fatty acids between lipid species within plant cells is only now starting to be 
appreciated. It is entirely possible for biosynthetic intermediates to be channelled into ‘metabolic 
cul-de-sacs’ rendering them unavailable for further desaturation, elongation or storage in seed oil.65 
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Historically, many of the individual genes necessary for LC omega-3 production were individually 
characterised in plants, indicating that in combination they would be successful. The first 
demonstration of EPA production in a transgenic plant was published by Qi et al.66 expressing the 
algal alternative pathway in the leaves of Arabidopsis thaliana. The approach used a series of 
sequential transformations of individual genes and resulted in the vegetative accumulation of EPA, 
predominantly in phospholipids. To be of economic value in the context of aquaculture as 
described above, it is necessary to have an engineered oilseed crop where the target LC omega-3 
would be produced and stored in the neutral lipids (triacylglycerol) of seeds at high levels. The 
possibility of LC omega-3 biosynthesis targeted to seeds was shown by Abbadi67 in which the 
conventional Δ6 pathway was expressed in transgenic linseed. Abbadi67 identified the presence of 
low levels of EPA in seeds, but concomitant with high levels of C18 Δ6-intermediates. The un-
wanted intermediates were the result of the poor acyl-exchange of intermediates between the acyl-
CoA pool (elongation) and glycerolipid pool (desaturation). Following these proof-of-concept 
studies efforts have continued to drive up the accumulation of LC omega-3 in seed oil and reduce 
the presence of intermediates e.g. Δ6 desaturation products like γ-linolenic acid. Such iterative 
engineering followed two strategies, the first utilised by Petrie and co-workers (CSIRO) made use 
of Agrobacterium-mediated transient expression of multiple gene combinations in Nicotiana 
benthamiana.68 Although testing was undertaken in leaves, the co-expression of the Lec2 
transcription factor or master regulator essentially ‘reprogrammed’ the leaf to replicate the lipid 
composition of a seed; a system that permitted the rapid selection of optimal gene combinations.  
The second approach, adopted by Heinz et al. (University of Hamburg) and Napier et al. 
(Rothamsted Research) was to directly assess gene combinations and their regulatory elements in 
the seeds of stably transformed plants (namely the oilseed model A. thaliana).69, 70 In combination 
with the development lipidomic approaches, it then enabled the evaluation of gene combination 
efficacy in the seed. Critical to the progress of these efforts was the use of omega-3 desaturases 
(reducing the accumulation of un-wanted omega-6 fatty acids) and the use of acyl-CoA dependent 
desaturases (breaking the desaturase/elongase substrate dichotomy).65 
 
7. Transition to Crops 
As described, the majority of the systematic work undertaken to produce a seed oil composition 
akin to fish oil (i.e. ~20% EPA and DHA in total fatty acids) was undertaken in model plant species 
i.e. arabidopsis and tobacco. However, to produce the volumes of LC omega-3 required by 
aquaculture necessitates the production of EPA and DHA in agricultural oilseed crops. The 
opportunities of scale associated with such crops provide the only chance to generate a fish oil 
substitute in significant quantities. From the available oilseed crops, screening has identified two as 
appropriate hosts for the production of LC omega-3; the first canola, a cultivar of rapeseed 
(Brassica napus L.) and secondly Camelina (Camelina sativa L). At this time no public data are 
available to assess the expression of the LC omega-3 trait in canola. However, two laboratories 
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(Rothamsted and CSIRO) have demonstrated the success of Camelina as a host for the 
accumulation of EPA and DHA in seed oil.71, 72 Camelina is an oilseed crop of the Brassicaceae 
adapted to temperate growing regions, with a low input requirement, short crop cycle and disease 
resistance. In terms of performance, Camelina has an acceptable yield (levels over 3000 kg/ha 
have been achieved)with an oil content of ~40%. Of interest to metabolic engineers, Camelina is 
an excellent platform for the production of tailored oils; it has very low outcrossing levels, and fully 
developed tools for breeding and molecular trait improvement due to the high sequence identity 
with Arabidopsis. Furthermore, genetic transformation is possible using Agrobacterium-mediated 
floral dip. However, it is the unique fatty acid composition of Camelina (unusual for a Brassicaceae 
the polyunsaturated α-linolenic acid (18:3) and linoleic acid (18:2) – substrates for LC omega-3 
synthesis - are the major fatty acids, whilst erucic acid (22:1) is low) that engenders this host to 
genetic engineering approaches73. 
 
Although different approaches were taken by Rothamsted and CSIRO, both demonstrated the 
suitability of Camelina as a host for the production of LC omega-3 in seeds. Researchers at 
Rothamsted used knowledge acquired from earlier engineering in Arabidopsis, introducing two 
optimised constructs into Camelina – one producing EPA alone and the other making both EPA 
and DHA. Analysis of the seed fatty acid composition from the stable transgenic lines revealed the 
average level of EPA alone was 24%, and for EPA and DHA, 11 and 8% respectively72. 
Significantly in both constructs only very low levels of C18 intermediates were recorded. Overall, 
the average total level of LC omega-3 was 19% (EPA + DHA) and much higher (25%) in some 
single seeds (see Fig 2)72Authors are these % of seed dm or of lipid?. The reported work from 
CSIRO showed significant accumulations of DHA with all the introduced constructs (12% with 
construct combination GA7 and mod-F), however levels of EPA were low (~3% for mod-F).71 The 
differences in the accumulations of LC omega-3 in Camelina can be attributed to a number of 
factors e.g. selection of seed-specific promoter, choice of Camelina strain, activity of each enzyme 
choice, constructs design/orientation, and possibly site of integration. For example, it is likely that 
the use of a highly active Δ5-elongase resulted in the specific difference in EPA accumulation65. 
Moreover, field evaluation of the LC omega-3 trait (EPA + DHA) in Camelina was undertaken at 
Rothamsted, where the feasibility was demonstrated (by comparison to replicated glasshouse 
experiments) of producing LC omega-3 in the field without any yield penalty74. Thus, the choice of 
the oilseed crop Camelina as a host for the successful expression of the LC omega-3 trait has 
been established. 
 
8. Utility of Camelina LC Omega-3 Oil in Aquaculture 
The essential question must be; can the novel LC omega-3 oils generated in Camelina be used as 
a substitute for fish oil? To address this Betancor et al.75 recently completed a study in which the 
EPA-containing Camelina oil described by Ruiz-Lopez et al.72 was tested as a substitute for fish oil 
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in a salmon feeding trial. In this study, fish oil (control), wild type (WT) and EPA-containing 
Camelina oil (GM) were fed to juvenile Atlantic salmon within an iso-energetic diet for a period of 
seven weeks. At the end of the feeding trial all the fish had doubled in weight and displayed no 
indicators of ill health; moreover fatty acid analysis indicated the expected accumulation of EPA. 
Further transcriptomic analysis produced a similar pattern of gene up regulation in fish receiving  
WT and GM Camelina oil; reflecting the fact that the GM Camelina oil is a modified vegetable oil 
and therefore contains a different chemical e.g. sterol composition to fish oil75. As formulations for 
aquafeed diets are now composed of blended fatty acids from marine and vegetable sources, the 
Betancor study successfully demonstrated how LC omega-3 Camelina oil is appropriate for use in 
aquaculture. (Authors can fish desaturate and elongate EPA to 22:6	(n-3) ? probably not!) 
 
9. Conclusion 
As discussed above there is a clear need within aquaculture for an alternative, sustainable supply 
of LC omega-3. The potential of engineered oilseed crops to meet this demand have been 
developed by a number of laboratories over the last fifteen years, but only now, at least with 
Camelina, has it been possible to demonstrate the viability of oilseed crops as a source of EPA 
and DHA. However, it is clear there are a number of hurdles before a Camelina LC omega-3 oil 
can become a commercial reality. It must be hoped that, subject to the appropriate regulatory and 
safety approvals, a forward looking aquafeed industry would be willing to adopt LC omega-3 
Camelina oil in fish diets, thereby reducing the pressure on oceanic stocks. Camelina engineered 
to produce EPA and DHA, when grown in sufficient volume could make a significant contribution to 
reducing the demand from capture fisheries (200 000 ha of LC omega-3 Camelina could produce 
150 000MT of oil or 15% of the global oceanic harvest).65 The area required seems large, but it is 
in fact modest when placed in the context of global vegetable oil production. For example, such a 
hypothetical area would be less than 3% of the Canadian oilseed sowing area of a crop like 
canola65. Of course before such numbers can be achieved on farms a number of issues must be 
resolved; crucially regulatory approval must be sought and obtained, the agronomy and breeding 
of Camelina must be addressed, oil formulations tested, and the views of consumers understood. 
All of these steps require significant effort and resolve, however the demand for LC omega-3 is  
likely to grow, therefore it is our hope that this experimental  terrestrial oilseed source of LC 
omega-3 can be converted to a commercial reality.  
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Table 1 International recommendations for dietary long-chain n-3 LC-PUFA consumption in 
humans. 
 
 Recommendation 
Source and reference Date Total n-3 ALA EPA+DHA n-3:n-6 
  
% of 
Metabolizable 
energy g/d mg/day  
NATO workshop 1989 — 3 800 4:1 
UK Committee on Medical Aspects 
of Food Policy 
1994 
0.2 — 100-200 — 
 ISSFAL workshop 1999 1 2.2 650 — 
Apports Nutritionnels Conseilles 
(France) 
2001 
0.8-1 1.8 450 (DHA, 110-120) 5:1 
Eurodiet 2000 — 2 200 — 
Health Council of the Netherlands 2001 1 — 200 7.5:1 
American Heart Association 2002 — — ~1 g/d (2ry prev CHD) — 
US National Academics of Science, 
Institute of Medicine 
2002 
— 1.4 ~140 — 
European Society of Cardiology 2003 — — ~1 g/d (2ry prev CHD) — 
WHO FAO 
2003 
1-2 — 
400-1000  
(1-2 fish meals/wk) — 
ISSFAL 2004 — 1.6 ≥500 — 
UK Scientific Advisory Committee 
on Nutrition 
2004 
— — 
~450 (Min 2 portions 
fish/wk)1 oily — 
 
ALA, α-linolenic acid; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; FAO, Food and 
Agriculture Organization; ISSFAL, International Society for the Study of Fatty Acids and Lipids; 
NATO, North Atlantic Treaty Organization; WHO, World Health Organization. 
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Table 2. World oil and fat production in 2012.a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a http://lipidlibrary.aocs.org/market/ofo6-07.htm (Updated 03/2013; accessed 10/2014) 
  
  Million tonnes (Mt/yr) 
Total production ~186 
  
Palm 50.7 
Soybean 42.4 
Rapeseed 24.3 
Sunflower 15.1 
Palmkernel 5.9 
Cottonseed 5.3 
Groundnut 5.1 
Coconut 3.6 
Olive 3.4 
Corn 2.5 
Sesame 0.8 
Linseed 0.6 
Castor 0.6 
Total vegetable oil 160.3 
  
Tallow ~ 9 
Lard ~ 8 
Butter ~ 7 
Fish ~ 1 
Total animal fat/oil ~ 25 
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Table 3. Fatty acid (FA) composition (Mol%) of major vegetable oils and animal fats. 
 
Oil/fat 16:0 18:0 18:1n-9 18:2n-6 18:3n-3 Significant other FAs 
High saturated 44 4 39 11 0  
Palm 9 3 15 2 0 70 (sat.* <16:0) 
Palm kernal 9 2 7 2 0 79 (sat. < 16:0) 
Coconut       
High 18:1n-9 4 1 62 22 10  
Rapeseed 10 2 78 7 0.6  
Olive       
High 18:2n-6 11 4 23 54 8  
Soybean 6 5 20 69 tr  
Sunflower 22 3 19 54 0.7  
Cottonseed 12 3 37 41 0.3 7 (LC-sat./mono.*) 
Groundnut 11 2 25 60 1  
Maize (Corn) 9 6 38 45 0.6  
Sesame 44 4 39 11 0  
High 18:3n-3       
Linseed 6 3 17 14 60  
Perilla 6 2 12 16 64  
Camelina 5 2 12 15 47 19 (C20 mono.) 
High D6 products       
Borage 10 4 18 36 tr 26 (18:3n-6), 6 (C20/22) 
Evening primrose 8 2 11 68 tr 10 (18:3n-6) 
Echium 7 4 16 15 29 13 (18:3n-6), 12 18:4n-3) 
Buglossoides 4 2 7 11 39 5 (18:3n-6), 18 (18:4n-3) 
Animal fats       
Tallow 25 19 43 2 1 4 (16:1) 
Lard 26 14 44 9 tr 3 (16:1) 
Poultry 23 6 42 19 tr 6 (16:1) 
*Sat.,saturated FA; Mono., monounsaturated FA 
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Table 4. Effect of complete or partial replacement of dietary fish oils by vegetable oils on fatty acid 
compositions (percentage of weight of total lipid) of flesh of Atlantic salmon. FO, fish oil; LO, 
Linseed oil; PO, palm oil; RO, rapeseed (Canola) oil; SO, sunflower oil; VO, vegetable oil blend; a 
Initial wt. 55 g / 100 % replacement / 30 weeks, b Initial wt. 80 g / 100 % replacement / 17 weeks, c 
Initial wt. 22 g / 100 % replacement / 9 weeks, d Initial wt. 127 g / 100 % replacement / 40 weeks), e 
Initial wt. 0.16g / 100 % replacement, RO/PO/LO [3.7:2:1] / 22 months. Authors, this is unclear to 
me	
               
	 FO POa 	 FO ROb 	 FO SOc 	 FO LOd 	 FO VOe 
14:0 4.2 1.6  3.9 1.4  5.2 2.2  4.7 0.7  4.9 0.8 
16:0 17.8 23.6  17.3 10.3  17.8 12.0  12.9 8.3  13.0 12.9 
18:0 2.9 3.7  2.7 2.7  4.8 5.6  1.9 3.6  2.6 3.1 
Total	saturated 25.9 29.2  24.5 14.8  28.9 21.0  19.9 12.7  21.1 17.0 
               
16:1n-7 4.9 1.3  5.0 1.8  6.8 2.6  7.5 0.8  4.4 0.9 
18:1n-9 18.3 37.2  17.1 39.1  16.3 19.8  16.0 18.6  14.6 41.3 
18:1n-7 2.9 1.6  2.6 3.2  3.5 2.7  3.8 1.3  2.7 2.5 
20:1n-9 4.8 3.4  7.6 4.1  1.4 1.0  16.6 1.6  11.4 2.7 
22:1n-11 4.8 1.8  8.9 2.6  NR NR  9.9 1.1  12.3 1.3 
Total	monoenes 37.6 46.2  42.3 51.8  30.8 26.7  57.1 24.2  48.2 49.0 
               
18:2n-6 3.4 10.6  2.5 12.3  3.5 33.2  3.9 13.1  3.3 14.4 
20:2n-6 0.5 1.0  0.4 1.2  0.3 1.4  0.4 0.7  0.4 1.2 
20:3n-6 0.1 0.6  0.1 0.5  NR NR  0.2 0.1  0.1 0.7 
20:4n-6 0.5 0.4  0.5 0.4  0.9 0.7  0.3 0.1  0.7 0.9 
Total	n-6	PUFA 4.8 12.7  3.7 14.6  5.4 37.6  4.9 14.0  4.5 17.0 
               
18:3n-3 1.8 0.5  1.4 5.6  NR NR  0.8 38.7  1.1 8.2 
18:4n-3 2.0 0.4  2.0 0.7  3.0 1.1  1.5 1.2  1.5 1.2 
20:4n-3 1.5 0.4  1.5 0.7  1.2 0.5  1.2 1.8  1.4 0.9 
20:5n-3 5.7 1.9  5.8 2.8  9.8 2.8  4.3 1.3  4.6 1.6 
22:5n-3 1.9 0.6  2.1 1.1  3.4 1.0  1.5 0.4  2.1 0.6 
22:6n-3 16.3 7.7  14.8 7.2  14.0 8.0  8.1 3.1  12.7 3.4 
Total	n-3	PUFA 29.5 11.5  27.7 18.4  31.3 13.5  17.5 49.1  23.4 16.0 
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Table 5. Potential annual demand for n-3 LC-PUFA based on recommended intake for reduction of 
risk of cardio-vascular disease compared with global annual supply from major sources. 
 
  Million tonnes Notes 
Demand (3.5g/week x 52 weeks x 7 billion) 1.274 Based on 500 mg/day (ISSFAL, 2004) 
Supply (see below) 0.84 Less than 2/3. See below for breakdown 
Gap (Demand - Supply) 0.434  
Capture fisheries (food)   
Landed 75.0 FAO, 2014. 
Edible yield (50%) 37.5  
Lipid content (5%) 1.875  
n-3 LC-PUFA content (20%) 0.375  
Capture fisheries (animal feed)   
Landed 20.0 FAO, 2014. 
Fishmeal produced (22%) 4.4 Fishmeal yield generally constant at 22% 
Lipid content (10%) 0.44  
n-3 LC-PUFA content (25%) 0.11  
Fish oil produced 1.0 Oil yield is variable 
n-3 LC-PUFA content (25%) 0.25  
Seafood by-products (incl. aquaculture)  About 50 % of by-products are produced  
Fishmeal produced 2.0 from aquaculture and, therefore, the  
Lipid content (5%) 0.1 n-3 LC-PUFA is mainly  derived from 
n-3 LC-PUFA content (10%) 0.01 fishmeal and fish oil and , as such,  
Fish oil produced 0.2 already counted above. 
n-3 LC-PUFA content (10%) 0.02  
Aquaculture (unfed)  Mainly filter-feeding carps (7.1 mt) and 
Produced 20.5 bivalves (13.4 mt) (FAO, 2014) 
Edible yield (50%) 10.25  
Lipid content (5%) 0.525  
n-3 LC-PUFA content (10%) 0.05  
Aquaculture (endogenous production) NA Salmonids and fed freshwater species1 
Macroalgae  Including species used for carageenin, 
Produced 23.8 algin, agar and iodine (~16 mt) 
Food or feed use 7.0 Human consumption & aquaculture 
Lipid content (2%) 0.14  
n-3 LC-PUFA content (15%) 0.02   
 
Production figures are from 2012 (FAO, 2014). All lipid and n-3 LC-PUFA contents/yields are 
estimated averages over the wide range of species in each category. 1Salmonids include 
salmon and trout spp. Freshwater species includes eels, tilapia and other freshwater species 
that still utilise some fishmeal and fish oil (13% of total fish oil used in aquaculture) in feeds. 
NA, not available. Although there will be some endogenous production of n-3 LC-PUFA 
inversely related to fishmeal and oil contents of feeds, this cannot be accurately estimated, but 
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will likely be minor based on volume of fish oil consumed by these sectors (75 % of all fish oil 
used in aquaculture). 
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